Prevalence of chronic obstructive pulmonary disease in Japanese people on medical check-up

Tohoku Journal of Experimental Medicine

Volumn 207, Issue 1, 2005, Pages 41-50

  Takemura, Hidekazu ^c,d   Hida, Wataru ^a   Sasaki, Tsukasa ^c   Sugawara, Takashi ^c   Sen, Tetsuzo ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b Iryohojin Shadan Shinkokai   (Japan)

^c SS30 Clinic Health Screening Center   (Japan)

^d SENDAI NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Epidemiology; Occupation; Smoker; Spirometry

Indexed keywords

ADULT; AGING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OCCUPATIONAL EXPOSURE; PREVALENCE; SEX DIFFERENCE; SMOKING; SPIROMETRY; TRAFFIC AND TRANSPORT;

ADULT; AGE FACTORS; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY;

EID: 23944443759     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.207.41     Document Type: Article

References (33)

1. American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis., 144, 1202-1218.
2. American Thoracic Society (1995a) Standardization of spirometry, 1994 undate. Am. J. Respir. Crit. Care Med., 152, 1107-1136.
3. American Thoracic Society (1995b) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 152, S77-S120.
4. American Thoracic Society (1996) Cigarette smoking and health. Am. J. Respir. Crit. Care Med., 153, 861-865.
5. Baldwin, E. deF., Cournand, A. & Richards, D.W., Jr. (1948) Pulmonary insufficiency. I. Physical classification, clinical methods of analysis, standard values in normal subjects. Medicine, 27, 243-278.
6. Barnes, P.J. (2000) Chronic obstructive pulmonary disease. N. Engl. J. Med., 343, 269-280.
7. British Thoracic Society (1997) BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax, 52, S1-S28.
8. de Marco, R., Accordini, S., Cerveri, I., Corsico, A. & Sunyer, J. (2004) An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax, 59, 120-125.
9. Ezzati, M. & Lopez, A.D. (2003) Estimates of global mortality attributable to smoking in 2000. Lancet, 362, 847-852.
10. Fukuchi, Y., Nishimura, M., Ichinose, M., Adachi, M., Nagai, A., Kuriyama, T., Takahashi, K., Nishimura, K., Ishioka, S., Aizawa, H. & Zaher, C. (2004) COPD in Japan: the Nippon COPD epidemiology study. Respirology, 9, 458-465.
11. Health and Welfare Statistics Association (2002) Journal of health and welfare statistics. Health and welfare statistics association, Tokyo. (in Japanese)
12. Hendrick, D.J. (1996) Occupational and chronic obstructive pulmonary disease (COPD). Thorax, 51, 947-955.
13. Hida, W., Tun, Y., Kikuchi, Y., Okabe, S. & Shirato, K. (2002) Pulmonary hypertension in patients with chronic obstructive pulmonary disease: recent advances in pathophysiology and management. Respirology, 7, 3-13.
14. Hnizdo, E., Sullivan, P.A., Bang, K.M. & Wagner, G. (2002) Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the third national health and nutrition examination survey. Am. J. Epidemiol., 156, 738-746.
15. Ichinose, M. (2003) Inflammatory mechanisms in bronchial asthma and COPD. Tohoku J. Exp. Med., 200, 1-6.
16. Japanese Respiratory Society (1999) Guideline for chronic obstructive pulmonary disease diagnosis and management. Medical review Co., Ltd., Tokyo. (in Japanese)
17. Lundback, B., Nystrom, L., Rosenhall, L. & Stjernberg, N. (1991) Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur. Respir. J., 4, 257-266.
18. Merget, R., Bauer, T., Küpper, H.U., Philippou, S., Bauer, H.D., Breitstadt, R. & Bruening, T. (2002) Health hazards due to the inhalation of amorphous silica. Arch. Toxicol., 75, 625-634.
19. Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labor and Welfare (2002) Guideline for epidemiological study (in Japanese). Available at: http://www.mhlw.go.jp/shingi/2002/12/s1211-9e.html.
20. Ministry of Health, Labor and Welfare (1999) Patient survey 1999 (in Japanese). Available at: http://wwwdbtk.mhlw.go.jp/toukei/data/150/1999/toukeihyou/0003543/ t0056317/ e97_060.html.
21. Murray, C.J.L. & Lopez, A.D. (1997) Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet, 349, 1498-1504.
22. National Institutes of Health, National Heart, Lung, and Blood Institute (2001) Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WH0 workshop report.
23. Pena, V.S., Miravitlles, M., Gabriel, R., Jiménez-Ruiz, C.A., Villasante, C., Masa, J.F., Viejo, J.L. & Fernández-Fau, L. (2000) Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest, 118, 981-989.
24. Rennard, S., Decramer, M., Calverley, P.M., Pride, N.B., Soriano, J.B., Vermeire, P.A. & Vestbo, J. (2002) Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey. Eur. Respir. J., 20, 799-805.
25. Scanlon, P.D., Connett, J.E., Waller, L.A., Altose, M.D., Bailey, W.C., Buist, A.S. & Tashkin, D.P. (2000) Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the lung health study. Am. J. Respir. Crit. Care Med., 161, 381-390.
26. Siafakas, N.M., Vermeire, P., Pride, N.B., Paoletti, P., Gibson, J., Howard, P., Yernault, J.C., Decramer, M., Higenbottam, T., Postma, D.S. & Rees, J. (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J., 8, 1398-1420.
27. Silverman, E.K. & Speizer, F.E. (1996) Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. North Am., 80, 501-522.
28. Sobti, R.C., Sharma, S., Joshi, A., Jindal, S.K. & Janmeja, A. (2003) CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers, 8, 415-428.
29. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labor and Welfare (2003) Vital statistics of Japan 2001. Health and welfare association, Tokyo. (in Japanese)
30. Takahashi, T., Ichinose, M., Inoue, H., Shirato, K., Hattori, T. & Takishima, T. (2003) Underdiagnosis and undertreatment of COPD in primary care settings. Respirology, 8, 504-508.
31. Takemura, H., Hida, W., Sasaki, T., Miura, N. & Sen, T. (2003) Prevalence of chronic obstructive pulmonary disease and smoking habit in subjects on human dry dock. Health Evaluation and Promotion, 30, 217-221. (in Japanese)
32. Thom, T.J. (1989) International comparisons in COPD mortality. Am. Rev. Respir. Dis., 140, S27-S34.
33. Viegi, G. (2001) Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration, 68, 4-19.